Evidence map›Paper›PMID 25458695›Full record

ArticleMolecular and cellular endocrinology2015

3β-Hydroxysteroid dehydrogenase isoforms in human aldosterone-producing adenoma.

Sachiko Konosu-Fukaya, Yasuhiro Nakamura, Fumitoshi Satoh, Saulo J A Felizola, Takashi Maekawa, Yoshikiyo Ono, Ryo Morimoto, Kazue Ise, Ken-Ichiro Takeda, Koshin Katsu and 9 more

Abstract read
In one paragraph

Article in Molecular and cellular endocrinology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Histopathological Classification of Cross-Sectional Image-Negative Hyperaldosteronism.The Journal of clinical endocrinology and metabolism · 2017
    Article
  14. Review
  15. Immunohistochemistry of the adrenal in primary aldosteronism.Current opinion in endocrinology, diabetes, and obesity · 2016
    Review
  16. Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 2 countries.

Sachiko Konosu-FukayaDepartment of Pathology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Yasuhiro NakamuraDepartment of Pathology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Fumitoshi SatohDivision of Nephrology, Endocrinology and Vascular Medicine, Department of Medicine, Tohoku University Hospital, Sendai, Japan.
Saulo J A FelizolaDepartment of Pathology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Takashi MaekawaDepartment of Pathology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Yoshikiyo OnoDivision of Nephrology, Endocrinology and Vascular Medicine, Department of Medicine, Tohoku University Hospital, Sendai, Japan.
Ryo MorimotoDivision of Nephrology, Endocrinology and Vascular Medicine, Department of Medicine, Tohoku University Hospital, Sendai, Japan.
Kazue IseDepartment of Pathology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Ken-Ichiro TakedaTohoku University School of Medicine, Sendai, Japan.
Koshin KatsuTohoku University School of Medicine, Sendai, Japan.
Fumiyoshi FujishimaDepartment of Pathology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Atsuko KasajimaDepartment of Pathology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Mika WatanabeDepartment of Pathology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Yoichi AraiDepartment of Urology, Tohoku University School of Medicine, Sendai, Japan.
Elise P Gomez-SanchezEndocrine Section, G.V. (Sonny) Montgomery VA Medical Center, MS, USA; Endocrinology, University of Mississippi Medical Center, Jackson, MS, USA; Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, MS, USA.
Celso E Gomez-SanchezEndocrine Section, G.V. (Sonny) Montgomery VA Medical Center, MS, USA; Endocrinology, University of Mississippi Medical Center, Jackson, MS, USA.
Masao DoiDepartment of Systems Biology, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan.
Hitoshi OkamuraDepartment of Systems Biology, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan.
Hironobu SasanoDepartment of Pathology, Tohoku University Graduate School of Medicine, Sendai, Japan. Electronic address: hsasano@patholo2.med.tohoku.ac.jp.
Tohoku University · JPTohoku University Hospital · JPKyoto University · JPG.V. (Sonny) Montgomery VA Medical Center · USUniversity of Mississippi Medical Center · US

Funding

ROLE OF MINERALOCORTICOIDS IN LOW-RENIN HYPERTENSIONR01HL027255 · NHLBI · UNIVERSITY OF SOUTH FLORIDA · PI GOMEZ-SANCHEZ, CELSO ENRIQUE · 1985 to 2017
$3.9M
NHLBI NIH HHS R01 HL027255NHLBI NIH HHS R01HL27255
6 · The paper itself

Abstract

It has become important to evaluate the possible involvement of 3β-hydroxysteroid dehydrogenase type 1 (HSD3B1) and 2 (HSD3B2) isoforms in aldosterone-producing adenoma (APA). In this study, we studied 67 and 100 APA cases using real-time quantitative PCR (qPCR) and immunohistochemistry, respectively. Results of qPCR analysis demonstrated that HSD3B2 mRNA was significantly more abundant than HSD3B1 mRNA (P < 0.0001), but only HSD3B1 mRNA significantly correlated with CYP11B2 (aldosterone synthase) mRNA (P <0.0001) and plasma aldosterone concentration (PAC) of the patients (P <0.0001). Results of immunohistochemistry subsequently revealed that HSD3B2 immunoreactivity was detected in the great majority of APA but a significant correlation was also detected between HSD3B1 and CYP11B2 (P <0.0001). In KCNJ5 mutated APA, CYP11B2 mRNA (P <0.0001) and HSD3B1 mRNA (P = 0.011) were significantly higher than those of wild type APA. These results suggest that HSD3B1 is involved in aldosterone production, despite its lower levels of expression compared with HSD3B2, and also possibly associated with KCNJ5 mutation in APA.

Indexed as

AdenomaAldosteroneGene Expression Regulation, EnzymologicGene Expression Regulation, NeoplasticHumansImmunohistochemistryIsoenzymesMultienzyme ComplexesProgesterone ReductaseReal-Time Polymerase Chain ReactionSteroid Isomerases3 beta-hydroxysteroid dehydrogenase type II3 beta-hydroxysteroid oxidoreductase-delta(5) 3-ketosteroid isomeraseAldosteroneIsoenzymesMultienzyme ComplexesProgesterone ReductaseSteroid Isomerases3β-hydroxysteroid dehydrogenase type 1 (HSD3B1)3β-hydroxysteroid dehydrogenase type 2 (HSD3B2)Aldosterone-producing adenoma (APA)CYP11B1 (11β-hydroxylase) and KCNJ5CYP11B2 (aldosterone synthase)

Identifiers

PMID25458695
PMCPMC4821076
OpenAlexW2100891325

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.